An Act to promote transparency in prescription drug prices
By Mr. Collins, a petition (accompanied by bill, Senate, No. 552) of Nick Collins, Carmine Lawrence Gentile, Michael O. Moore, Rebecca L. Rausch and other members of the General Court for legislation to promote transparency in prescription drug prices. Financial Services.
Bill History
| Date | Branch | Action |
|---|---|---|
| 1/22/2019 | Senate | Referred to the committee on Financial Services |
| 1/22/2019 | House | House concurred |
| 9/12/2019 | Joint | Hearing scheduled for 09/23/2019 from 11:00 AM-03:00 PM in Gardner Auditorium |
| 2/18/2020 | Senate | Accompanied a study order, see S2543 SJ 1251 - 1252. |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.